Eric Ostertag, M.D., Ph.D., is a key figure in the biotechnology world, having led Poseida Therapeutics as the CEO before becoming the Executive Chairman. His educational background is impressive; he holds both an M.D. and a Ph.D. from the University...
Eric Ostertag, M.D., Ph.D., is a key figure in the biotechnology world, having led Poseida Therapeutics as the CEO before becoming the Executive Chairman. His educational background is impressive; he holds both an M.D. and a Ph.D. from the University of California, San Diego. Under his leadership, Poseida Therapeutics focused on innovative treatments in genetic therapies and cell therapy, aiming to change the standard of care in the industry. Eric is also a savvy investor, having made significant insider trades, including transactions that have moved millions in worth, particularly in 2021, when he traded stocks valued over $41 million in a single month. Despite stepping down as CEO in early 2022, he continues to influence Poseida’s strategic direction and scientific advancements. His unique blend of medical knowledge and business acumen positions him as a significant player not only in biotech but also in investment circles. His transition to Executive Chairman didn't change his hands-on approach to guiding the company through its next stages. With a vested interest in Poseida’s success, he plans to continue contributing to the company's research and innovation goals.